In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Inhaled insulin is an “important alternative” to injected rapid-acting analog insulin for children and teens with diabetes, ...

The company plans to submit efsitora, its once-weekly insulin for type 2 diabetes, to global regulators by end-2026 following ...

Eli Lilly's LLY.N experimental once-weekly insulin efsitora was comparable to daily insulins in nearly a thousand adults with type 2 diabetes in three late-stage trials, researchers reported at ...